Topics

Companies Related to "genomics profiling help identify best treatment bladder cancer∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

18:53 EDT 19th July 2019 | BioPortfolio

Here are the most relevant search results for "genomics profiling help identify best treatment bladder cancer∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "genomics profiling help identify best treatment bladder cancer" Companies 1–25 of 6,000+

Friday 19th July 2019

GenesisCare

GenesisCare delivers treatment to people with cancer and heart disease, the two largest disease burdens globally. We’re committed to leading the change in how care is designed and given and are currently leading or participating in more than 100 clinical trials.


Thursday 18th July 2019

Neurogene Inc.

Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs ...

Ardian

Ardian, Inc., headquartered in Palo Alto, California, is a private medical device company developing a novel catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. These interdependent disease states represent a significant, escalating global health issue. Ardian is the eighth company created...


Wednesday 17th July 2019

AUM Biosciences

AUM Biosciences (AUM) is an oncology-focused Asian biotechnology company committed to developing affordable cancer therapies. Dedicated to unlocking the value in innovation, AUM harnesses the power of precision medicine and digital health to support patients, physicians and partners. AUM focuses on early-stage development of innovative treatment of cancers prevalent in Asia with the potential to ...

Orum Therapeutics, Inc.

Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum...

Tuesday 16th July 2019

Constellation Behavioral Health

Founded in 2010, Constellation is dedicated to creating and operating innovative treatment programs for adults with addiction, mental health and co-occurring disorders. Constellation was founded on the belief that excellent treatment outcomes require an intense focus on diagnosing and treating co-occurring disorders, and that a treatment program’s success ...

Frelii, Inc.

Frelii Inc. is a biotech company that uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The results are aligned and leveraged against its AI, as a means of creating a very strong and powerful data platform for use by the Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical industries. Frelii’s technology...

Monday 15th July 2019

Imugene Ltd

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and oth...

SI-BONE, Inc.

SI-BONE, Inc. (Cupertino, California) is a leading spinal medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology. The company has developed, and is manufacturing and marketing, less invasive approaches using implants for the treatment of SI Joint pathology. SI-BONE has an exper...

Friday 12th July 2019

Alzamend Neuro, Inc.

Alzamend Neuro™, Inc. is a Delaware corporation with its corporate headquarters in the State of Florida. The mission of Alzamend Neuro™ is to support the full product development life cycle of treatment and cures for Alzheimer’s driven by the belief that strong support of research is the foundation for true innovation. The Company is providing current hope through the commercializa...

Thursday 11th July 2019

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...

Tuesday 9th July 2019

Psychiatric Medical Care, LLC

Founded in 2003 and based in Nashville, TN, Psychiatric Medical Care (PMC) is a leading behavioral healthcare management company focused on addressing the needs of rural and underserved communities. Operating in more than 20 states, the company manages both inpatient psychiatry units and intensive outpatient psychiatry programs within hospitals. PMC also provides telepsychiatry services across a ...

Monday 8th July 2019

Silicon Therapeutics

Silicon Therapeutics (“SiTX”) is a physics-driven drug discovery company focused on small molecule therapeutics for cancer that target innate immunity to “light the spark” within immunologically cold tumors. The company’s unique computational physics-based platform can accurately simulate the physical motion and properties of biological targets at atomistic resolution to ...

OncoSenX, Inc.

OncoSenX is a late preclinical-stage oncology company developing therapeutics to kill cancer cells based on their genetics. Headquartered in Seattle, Washington, the company’s technology platform targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA approach. For more information, visit www.oncosenx.com.

CTD Holdings, Inc.

CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical t...

Friday 5th July 2019

COBO Technologies

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.

ACT Genomics Holdings Co., Ltd

Location

Wednesday 3rd July 2019

Onco360® Oncology Pharmacy

Onco360 is the largest independent Oncology Pharmacy and clinical support services company in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of U...

Monday 1st July 2019

Century Therapeutics

Century Therapeutics is harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. Century’s genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers. Its commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity t...

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of small molecule drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across m...

Friday 28th June 2019

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Thursday 27th June 2019

Elite Skin & Lash

Serving Colleyville, Southlake, Westlake, Fort Worth, Keller, and the surrounding areas, Elite Skin and Lash offers an array of treatments ranging from facials, microdermabrasion, chemical peels, eyelash extensions, massage, laser, and skin tightening services. The clinical result-driven treatments including age management, anti-aging, pigmentation, wrinkle treatment, and acne treatment are alway...

ImmunoGen

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company's product candidates arecalled tumor-activated prodrugs ("TAPs") and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, TAPs are intended to deliver potent chemotherapy specifically to a tumor. Each TAP immunoconjugate comprises a small-molecule d...

Morphic Holding, Inc.

Morphic Therapeutic, Inc. is a biopharmaceutical company applying its proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Morphic has developed an exclusive technology platform by...

Wednesday 26th June 2019

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...


More From BioPortfolio on "genomics profiling help identify best treatment bladder cancer∨derfield=score∨derval=DESC"

Quick Search

Corporate Database Quicklinks